These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22337081)

  • 21. Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5.
    Li Z; Zhou J; Zhang J; Li S; Wang H; Du J
    Int J Cancer; 2019 Oct; 145(7):1946-1957. PubMed ID: 30873585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II induces tumor progression and fibrosis in intrahepatic cholangiocarcinoma through an interaction with hepatic stellate cells.
    Okamoto K; Tajima H; Ohta T; Nakanuma S; Hayashi H; Nakagawara H; Onishi I; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Tani T; Fujimura T; Kayahara M; Harada S; Wakayama T; Iseki S
    Int J Oncol; 2010 Nov; 37(5):1251-9. PubMed ID: 20878072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Periostin activates integrin α5β1 through a PI3K/AKT‑dependent pathway in invasion of cholangiocarcinoma.
    Utispan K; Sonongbua J; Thuwajit P; Chau-In S; Pairojkul C; Wongkham S; Thuwajit C
    Int J Oncol; 2012 Sep; 41(3):1110-8. PubMed ID: 22735632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor Lymphatic Interactions Induce CXCR2-CXCL5 Axis and Alter Cellular Metabolism and Lymphangiogenic Pathways to Promote Cholangiocarcinoma.
    Roy S; Kumaravel S; Banerjee P; White TK; O'Brien A; Seelig C; Chauhan R; Ekser B; Bayless KJ; Alpini G; Glaser SS; Chakraborty S
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma.
    Gentilini A; Rombouts K; Galastri S; Caligiuri A; Mingarelli E; Mello T; Marra F; Mantero S; Roncalli M; Invernizzi P; Pinzani M
    J Hepatol; 2012 Oct; 57(4):813-20. PubMed ID: 22727731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.
    Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C
    Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Akt expression may predict favorable prognosis in cholangiocarcinoma.
    Javle MM; Yu J; Khoury T; Chadha KS; Iyer RV; Foster J; Kuvshinoff BW; Gibbs JF; Geradts J; Black JD; Brattain MG
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1744-51. PubMed ID: 16984600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased roundabout 1 expression promotes development of intrahepatic cholangiocarcinoma.
    Mano Y; Aishima S; Fukuhara T; Tanaka Y; Kubo Y; Motomura T; Toshima T; Iguchi T; Shirabe K; Maehara Y; Oda Y
    Hum Pathol; 2013 Nov; 44(11):2419-26. PubMed ID: 23953227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
    Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y
    Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment.
    Dokduang H; Juntana S; Techasen A; Namwat N; Yongvanit P; Khuntikeo N; Riggins GJ; Loilome W
    Tumour Biol; 2013 Dec; 34(6):3519-28. PubMed ID: 23812726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients.
    Huang XY; Ke AW; Shi GM; Ding ZB; Devbhandari RP; Gu FM; Li QL; Dai Z; Zhou J; Fan J
    Cancer; 2010 Dec; 116(23):5440-51. PubMed ID: 20715158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery.
    Shi RY; Yang XR; Shen QJ; Yang LX; Xu Y; Qiu SJ; Sun YF; Zhang X; Wang Z; Zhu K; Qin WX; Tang ZY; Fan J; Zhou J
    Cancer; 2013 Mar; 119(5):993-1003. PubMed ID: 23132676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
    Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
    Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression and role of CXC chemokine 5 in liver cancer cells].
    Xu XJ; Yang BW; Gong FX; Huang PX; Wu WZ; Xia JL
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(38):2716-9. PubMed ID: 23290114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma.
    Alvaro D; Barbaro B; Franchitto A; Onori P; Glaser SS; Alpini G; Francis H; Marucci L; Sterpetti P; Ginanni-Corradini S; Onetti Muda A; Dostal DE; De Santis A; Attili AF; Benedetti A; Gaudio E
    Am J Pathol; 2006 Sep; 169(3):877-88. PubMed ID: 16936263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathobiological implications of MUC16/CA125 expression in intrahepatic cholangiocarcinoma-mass forming type.
    Higashi M; Yamada N; Yokoyama S; Kitamoto S; Tabata K; Koriyama C; Batra SK; Yonezawa S
    Pathobiology; 2012; 79(2):101-6. PubMed ID: 22286058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of galectin-3 is associated with metastatic potential of liver fluke-associated cholangiocarcinoma.
    Junking M; Wongkham C; Sripa B; Sawanyawisuth K; Araki N; Wongkham S
    Eur J Cancer; 2008 Mar; 44(4):619-26. PubMed ID: 18272359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.
    Cadamuro M; Nardo G; Indraccolo S; Dall'olmo L; Sambado L; Moserle L; Franceschet I; Colledan M; Massani M; Stecca T; Bassi N; Morton S; Spirli C; Fiorotto R; Fabris L; Strazzabosco M
    Hepatology; 2013 Sep; 58(3):1042-53. PubMed ID: 23505219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CEACAM6 gene expression in intrahepatic cholangiocarcinoma.
    Ieta K; Tanaka F; Utsunomiya T; Kuwano H; Mori M
    Br J Cancer; 2006 Aug; 95(4):532-40. PubMed ID: 16868542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.